Search research articles
Contact Us
Filters
Showing results (141-150 of 288) with videos related to
Page
of 29
Sort By:
Leukemia Research
|
November 15, 2000
Burkitt's lymphoma in Greek adults. A study of the Hellenic co-operative oncology group
T Economopoulos, M A Dimopoulos, A Foudoulakis, et al.
Blood Cancer Journal
|
November 12, 2016
Overexpression of RANKL by invariant NKT cells enriched in the bone marrow of patients with multiple myeloma
E Spanoudakis, M Papoutselis, E Terpos, et al.
Oncology
|
October 21, 1998
Sequential administration of doxorubicin and paclitaxel followed by cyclophosphamide, methotrexate and 5-fluorouracil combination (CMF) in women with metastatic breast cancer
C A Papadimitriou, M A Dimopoulos, C Ampela, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 10, 2011
The use of 24-h ambulatory blood pressure monitoring (ABPM) during the first cycle of sunitinib improves the diagnostic accuracy and management of hypertension in patients with advanced renal cancer
A Bamias, E Manios, A Karadimou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 21, 2000
Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: a phase II study conducted by the Hellenic Cooperative Oncology Group
C Nicolaides, M A Dimopoulos, E Samantas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 5, 2002
Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group
D Pectasides, G Aravantinos, H Kalofonos, et al.
Leukemia & Lymphoma
|
May 1, 1995
Rising serum lactate dehydrogenase often caused by granulocyte-or Granulocyte-macrophage colony stimulating factor and not tumor progression in patients with lymphoma or myeloma
A H Sarris, A Majlis, M A Dimopoulos, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 29, 2006
Brain metastases as isolated site of relapse in patients with epithelial ovarian cancer previously treated with platinum and paclitaxel-based chemotherapy
E Kastritis, E Efstathiou, D Gika, et al.
Mutation Research
|
February 4, 2010
Low frequency of somatic mutations in uterine sarcomas: a molecular analysis and review of the literature
S Murray, H Linardou, G Mountzios, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 1997
Ifosfamide and paclitaxel salvage chemotherapy for advanced epithelial ovarian cancer
M A Dimopoulos, C Papadimitriou, C Gennatas, et al.
Page
of 29
Search research articles
Search
Showing results (141-150 of 288) with videos related to
Sort By:
Page
of 29
Leukemia Research
|
November 15, 2000
Burkitt's lymphoma in Greek adults. A study of the Hellenic co-operative oncology group
T Economopoulos, M A Dimopoulos, A Foudoulakis, et al.
Blood Cancer Journal
|
November 12, 2016
Overexpression of RANKL by invariant NKT cells enriched in the bone marrow of patients with multiple myeloma
E Spanoudakis, M Papoutselis, E Terpos, et al.
Oncology
|
October 21, 1998
Sequential administration of doxorubicin and paclitaxel followed by cyclophosphamide, methotrexate and 5-fluorouracil combination (CMF) in women with metastatic breast cancer
C A Papadimitriou, M A Dimopoulos, C Ampela, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 10, 2011
The use of 24-h ambulatory blood pressure monitoring (ABPM) during the first cycle of sunitinib improves the diagnostic accuracy and management of hypertension in patients with advanced renal cancer
A Bamias, E Manios, A Karadimou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 21, 2000
Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: a phase II study conducted by the Hellenic Cooperative Oncology Group
C Nicolaides, M A Dimopoulos, E Samantas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 5, 2002
Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group
D Pectasides, G Aravantinos, H Kalofonos, et al.
Leukemia & Lymphoma
|
May 1, 1995
Rising serum lactate dehydrogenase often caused by granulocyte-or Granulocyte-macrophage colony stimulating factor and not tumor progression in patients with lymphoma or myeloma
A H Sarris, A Majlis, M A Dimopoulos, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 29, 2006
Brain metastases as isolated site of relapse in patients with epithelial ovarian cancer previously treated with platinum and paclitaxel-based chemotherapy
E Kastritis, E Efstathiou, D Gika, et al.
Mutation Research
|
February 4, 2010
Low frequency of somatic mutations in uterine sarcomas: a molecular analysis and review of the literature
S Murray, H Linardou, G Mountzios, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 1997
Ifosfamide and paclitaxel salvage chemotherapy for advanced epithelial ovarian cancer
M A Dimopoulos, C Papadimitriou, C Gennatas, et al.
Page
of 29